Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutical Statistics
|
December 18, 2020
A confidence function-based posterior probability design for phase II cancer trials
Minghua Shan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2010
Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Carol Peña, Chetan Lathia, Minghua Shan, et al.
Molecular Vision
|
September 24, 2005
Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy
Minghua Shan, Bing Dong, Xueqin Zhao, et al.
Trials
|
July 24, 2013
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial
José Baselga, Frederico Costa, Henry Gomez, et al.
Gynecologic Oncology
|
April 18, 2013
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma
Thomas J Herzog, Giovanni Scambia, Byoung-Gie Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial
Bernard Escudier, Tim Eisen, Walter M Stadler, et al.
The New England Journal of Medicine
|
January 12, 2007
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier, Tim Eisen, Walter M Stadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
The Lancet. Oncology
|
May 20, 2014
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Oliver Sartor, Robert Coleman, Sten Nilsson, et al.
The New England Journal of Medicine
|
July 25, 2008
Sorafenib in advanced hepatocellular carcinoma
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutical Statistics
|
December 18, 2020
A confidence function-based posterior probability design for phase II cancer trials
Minghua Shan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2010
Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Carol Peña, Chetan Lathia, Minghua Shan, et al.
Molecular Vision
|
September 24, 2005
Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy
Minghua Shan, Bing Dong, Xueqin Zhao, et al.
Trials
|
July 24, 2013
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial
José Baselga, Frederico Costa, Henry Gomez, et al.
Gynecologic Oncology
|
April 18, 2013
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma
Thomas J Herzog, Giovanni Scambia, Byoung-Gie Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial
Bernard Escudier, Tim Eisen, Walter M Stadler, et al.
The New England Journal of Medicine
|
January 12, 2007
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier, Tim Eisen, Walter M Stadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
The Lancet. Oncology
|
May 20, 2014
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Oliver Sartor, Robert Coleman, Sten Nilsson, et al.
The New England Journal of Medicine
|
July 25, 2008
Sorafenib in advanced hepatocellular carcinoma
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Page
of 1